Trexquant Investment LP Invests $11.87 Million in Revvity, Inc. (NYSE:RVTY)

Trexquant Investment LP purchased a new position in shares of Revvity, Inc. (NYSE:RVTY - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 106,340 shares of the company's stock, valued at approximately $11,869,000. Trexquant Investment LP owned about 0.09% of Revvity as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Assetmark Inc. lifted its position in shares of Revvity by 3,700.0% in the fourth quarter. Assetmark Inc. now owns 266 shares of the company's stock worth $30,000 after purchasing an additional 259 shares in the last quarter. Continuum Advisory LLC lifted its position in Revvity by 2,972.7% during the 3rd quarter. Continuum Advisory LLC now owns 338 shares of the company's stock worth $43,000 after buying an additional 327 shares in the last quarter. Millstone Evans Group LLC bought a new stake in Revvity during the 4th quarter worth about $38,000. MassMutual Private Wealth & Trust FSB boosted its stake in shares of Revvity by 55.9% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company's stock worth $43,000 after buying an additional 138 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its holdings in shares of Revvity by 33.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 522 shares of the company's stock valued at $58,000 after acquiring an additional 131 shares in the last quarter. 86.65% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research analysts recently commented on RVTY shares. Barclays increased their price target on Revvity from $135.00 to $140.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. KeyCorp increased their price objective on Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Raymond James reaffirmed an "outperform" rating and set a $145.00 price target (up from $140.00) on shares of Revvity in a research report on Monday, February 3rd. Bank of America raised shares of Revvity from a "neutral" rating to a "buy" rating and set a $138.00 price objective for the company in a research report on Friday, December 13th. Finally, Sanford C. Bernstein lowered shares of Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price objective on the stock. in a research note on Friday, January 10th. Four equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Revvity has a consensus rating of "Moderate Buy" and an average target price of $136.25.

Remove Ads

Insider Activity

In other news, insider Joel S. Goldberg sold 15,170 shares of the firm's stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total value of $1,922,494.10. Following the sale, the insider now directly owns 33,400 shares in the company, valued at approximately $4,232,782. This trade represents a 31.23 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Tajinder S. Vohra sold 5,492 shares of the company's stock in a transaction that occurred on Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total transaction of $641,520.52. Following the transaction, the insider now owns 19,652 shares of the company's stock, valued at approximately $2,295,550.12. This represents a 21.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.68% of the stock is owned by company insiders.

Revvity Stock Performance

Shares of NYSE RVTY traded up $0.63 during trading hours on Monday, reaching $95.47. 631,819 shares of the stock were exchanged, compared to its average volume of 882,991. The firm has a market capitalization of $11.47 billion, a price-to-earnings ratio of 43.00, a P/E/G ratio of 3.82 and a beta of 1.07. The stock's fifty day simple moving average is $113.18 and its 200 day simple moving average is $116.43. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.03 and a current ratio of 3.60. Revvity, Inc. has a 52 week low of $91.06 and a 52 week high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $1.42 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same quarter in the previous year, the business posted $1.25 EPS. Sell-side analysts predict that Revvity, Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Friday, April 18th will be issued a dividend of $0.07 per share. The ex-dividend date is Thursday, April 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.29%. Revvity's dividend payout ratio is presently 12.67%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.